Bioengineering Day 2015


Keynote Speaker


Dr Philip Low Dr. Philip Low, Founder, Chairman, and CEO of NeuroVigil
Philip Low is Chairman, Chief Scientific Officer and Chief Executive Officer of NeuroVigil and Research Collaborator at Salk Institute with previous appointments at the Stanford University School of Medicine and the Massachusetts Institute of Technology Media Lab. He is the inventor, neurotechnologist and computational neuroscientist responsible for the SPEARS algorithm, the iBrain neural monitor and the Cambridge Declaration on Consciousness.

During an undergraduate internship at Harvard Medical School, Dr. Low showed that Compound H, a Type I Collagen Inhibitor halts the spread of fibroid tumors. At The University of Chicago he invented a novel epidural EEG brain implant technique, which is now common practice in the field. During his doctoral studies at UC San Diego, he overturned longstanding beliefs regarding human and animal neural sleep patterns and developed the SPEARS algorithm for non-invasive single channel EEG recording. His Ph.D. thesis, a dynamic map of brain activity derived from a single non-invasive EEG channel, was one page and was unanimously approved by his committee. Dr. Low's work has been featured in technical and popular articles, including PNAS, The New York Times, and TIME.

In 2010, Dr. Low was named President of the 1st International Congress on Alzheimer's Disease and Advanced Neurotechnologies. In 2012 he chaired the first Francis Crick Memorial Conference in Cambridge, UK. He is also a scientific advisor to the White House and US-Israeli Science and Technology Foundation. While in graduate school he founded NeuroVigil, the neurodiagnostics company responsible for iBrain, a wireless portable neural monitoring platform used to non-invasively monitor neuropathologies and the response of the brain to pharmaceuticals. In 2011 he began a partnership with Stephen Hawking on Brain Based Communication systems. In 2013 and under Dr. Low's leadership, NeuroVigil expanded its operations to NASA to provide assistance to paralyzed individuals with communication challenges. In 2014, NeuroVigil further expanded its San Diego operations to provide assistance to homeless veterans suffering from post-traumatic stress or traumatic brain injuries.

He has received numerous prestigious academic and entrepreneurial honors and awards including the MIT Technology Review's "Top Young Innovator Under 35", KAVLI Brain and Mind Innovative Research Award, and first prize for the UCSD Entrepreneurship Challenge. Since 2005, Dr. Low has authored more than 35 patents, including the intellectual property used to found NeuroVigil.

Dr. Low holds a B.S. in Pure Mathematics from The University of Chicago and a Ph.D. in Computational Neurobiology from UC San Diego, where he was co-advised by Charles F. Stevens, Terrence J. Sejnowski, and Fred H. Gage. Subsequently, he completed his postdoctoral studies at Salk Institute.

If you have any questions, please email be-day@eng.ucsd.edu.

« Home

footer bar
All Content Copyright 2015 Regents of the University of California. All rights reserved.
Official Web page of the University of California, San Diego.